Optimisation of a Caprylic Acid-Based Protocol for IgG Purification from Baboon (Papio anubis) Serum
Abstract
1. Introduction
2. Materials and Methods
2.1. Ethical Approval and Animal Welfare
2.2. Collection of Blood Samples
Serum Preparation
2.3. Antibody Purification with Caprylic Acid: Before Optimisation
2.4. Optimisation and Standardisation of the Caprylic Acid Fractionation Protocol for Baboon Serum
2.4.1. Serum pH
2.4.2. Caprylic Acid Concentration
2.4.3. Stirring Intensity
2.4.4. Stirring Time
2.4.5. Dialysis Buffer Composition
2.4.6. Lyophilisation
2.5. Purification of Baboon Serum with Caprylic Acid After Optimisation of the Protocol
2.6. Characterisation of IgG Purified by Caprylic Acid Under Different Conditions
2.6.1. Protein Quantification
2.6.2. Sodium Dodecyl Sulphate–Polyacrylamide Gel Electrophoresis (SDS-PAGE)
2.6.3. Turbidity Measurement
2.7. Comparison of Caprylic Acid-Purified Baboon IgG with Commercial IgG Products
2.8. Statistical Analyses
3. Results
3.1. Determination of the Optimal Conditions for Fractionation of Baboon Serum with Caprylic Acid
3.1.1. pH Optimisation
3.1.2. Optimisation of Caprylic Acid Concentration
3.1.3. Optimisation of Stirring Intensity
3.1.4. Optimisation of Stirring Time
3.1.5. Optimisation of Dialysis Buffer
3.1.6. Effect of Lyophilisation on Final IgG Product
3.2. Analysis of Purified Baboon IgG Before and After Optimisation of the Caprylic Acid Fractionation Method
3.3. Comparison of Caprylic Acid Purified Baboon IgG with Commercial IgG Products
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| CA | Caprylic acid |
| Igs | Immunoglobulins |
| OFAT | One factor at a time |
| HIV | Human immunodeficiency virus |
| CEA | Carcinoembryonic antigen |
| USA | United States of America |
| UK | United Kingdom |
| IgG | Immunoglobulin G |
| SDS-PAGE | Sodium dodecyl sulfate–polyacrylamide gel electrophoresis |
| v/v | Volume per volume |
| NaOH | Sodium hydroxide |
| MWCO | Molecular weight cut-off |
| SCS | Sodium citrate-buffered saline |
| PBS | Phosphate-buffered saline |
| SPB | Sodium phosphate buffer |
| ANOVA | Analysis of variance |
| PAUSTI | Pan-African University Institute for Basic Sciences, Technology and Innovation |
| K-SRIC | Kenya Snakebite Research and Intervention Centre |
| KIPRE | Kenya Institute of Primate Research |
References
- Jamal, Z.; Patel, P.; Ramphul, K. Immunoglobulin. In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, USA, 2023. Available online: https://www.ncbi.nlm.nih.gov/books/NBK513460/ (accessed on 20 November 2025).
- Attanasio, R.; Jayashankar, L.; Engleman, C.N.; Scinicariello, F. Baboon Immunoglobulin Constant Region Heavy Chains: Identification of Four IGHG Genes. Immunogenetics 2002, 54, 556–561. [Google Scholar] [CrossRef] [PubMed]
- Scinicariello, F.; Jayashankar, L.; Attanasio, R. Baboon Immunoglobulin Variable Region Heavy Chains: Identification of Genes Homologous to Members of the Human IGHV1-IGHV7 Subgroups. Immunogenetics 2002, 53, 815–820. [Google Scholar] [CrossRef] [PubMed]
- Tarantal, A.F.; Noctor, S.C.; Hartigan-O’connor, D.J. Nonhuman Primates in Translational Research. Annu. Rev. Anim. Biosci. 2022, 10, 441–468. [Google Scholar] [CrossRef] [PubMed]
- Cox, L.A.; Comuzzie, A.G.; Havill, L.M.; Karere, G.M.; Spradling, K.D.; Mahaney, M.C.; Nathanielsz, P.W.; Nicolella, D.P.; Shade, R.E.; Voruganti, S.; et al. Baboons as a Model to Study Genetics and Epigenetics of Human Disease. ILAR J. 2013, 54, 106–121. [Google Scholar] [CrossRef]
- Mulholland, M.M.; Nehete, B.P.; DeLise, A.; Achorn, A.M.; Pytka, L.M.; Nehete, P.N. Age-Associated Alterations in Immune and Inflammatory Responses in Captive Olive Baboons (Papio anubis). Front. Aging 2024, 5, 1511370. [Google Scholar] [CrossRef]
- Rivera-Hernandez, T.; Carnathan, D.G.; Moyle, P.M.; Toth, I.; West, N.P.; Young, P.L.; Silvestri, G.; Walker, M.J. The Contribution of Non-Human Primate Models to the Development of Human Vaccines. Discov. Med. 2014, 18, 313–322. [Google Scholar]
- Hefty, P.S.; Brooks, C.S.; Jett, A.M.; White, G.L.; Wikel, S.K.; Kennedy, R.C.; Akins, D.R. OspE-Related, OspF-Related, and Elp Lipoproteins Are Immunogenic in Baboons Experimentally Infected with Borrelia burgdorferi and in Human Lyme Disease Patients. J. Clin. Microbiol. 2002, 40, 4256–4265. [Google Scholar] [CrossRef]
- Losman, M.J.; Monestier, M.; Hansen, H.J.; Goldenberg, D.M. Baboon anti-idiotype antibodies mimic a carcinoembryonic antigen epitope. Int. J. Cancer 1990, 46, 310–314. [Google Scholar] [CrossRef]
- Arakawa, T.; Tomioka, Y.; Nakagawa, M.; Sakuma, C.; Kurosawa, Y.; Ejima, D.; Tsumoto, K.; Akuta, T. Non-Affinity Purification of Antibodies. Antibodies 2023, 12, 15. [Google Scholar] [CrossRef]
- Milne, J.J. Scale-Up of Protein Purification: Downstream Processing Issues. Methods Mol. Biol. 2017, 1485, 71–84. [Google Scholar] [CrossRef]
- Mukhtar, H.; Majeed, Z.; Naseer, B.; Iftikhar Shah, F. Efficiency of Purification Techniques of Human IgG—A Review. J. Bacteriol. Mycol. Open Access 2021, 9, 15–23. [Google Scholar] [CrossRef]
- O’Kennedy, R.; Murphy, C.; Devine, T. Technology Advancements in Antibody Purification. Antib. Technol. J. 2016, 6, 17–32. [Google Scholar] [CrossRef]
- Van Alstine, J.M.; Jagschies, G.; Łacki, K.M. Alternative Separation Methods: Flocculation and Precipitation. In Biopharmaceutical Processing: Development, Design, and Implementation of Manufacturing Processes; Jagschies, G., Lindskog, E., Łącki, K., Galliher, P., Eds.; Elsevier: Amsterdam, The Netherlands, 2018; pp. 221–239. [Google Scholar] [CrossRef]
- Brodsky, Y.; Zhang, C.; Yigzaw, Y.; Vedantham, G. Caprylic Acid Precipitation Method for Impurity Reduction: An Alternative to Conventional Chromatography for Monoclonal Antibody Purification. Biotechnol. Bioeng. 2012, 109, 2589–2598. [Google Scholar] [CrossRef] [PubMed]
- Shawki, A.; Abd El-Baky, N.; Ahmed, M.; Linjawi, M.H.; Aljaddawi, A.A.; Redwan, E.M. Simple Protocol for Immunoglobulin G Purification from Camel “Camelus dromedarius” Serum. Open Life Sci. 2017, 12, 143–155. [Google Scholar] [CrossRef]
- Nudel, B.C.; Perdoménico, C.; Iácono, R.; Cascone, O. Optimization by Factorial Analysis of Caprylic Acid Precipitation of Non-Immunoglobulins from Hyperimmune Equine Plasma for Antivenom Preparation. Toxicon 2012, 59, 68–73. [Google Scholar] [CrossRef]
- Trapp, A.; Faude, A.; Hörold, N.; Schubert, S.; Faust, S.; Grob, T.; Schmidt, S. Multiple Functions of Caprylic Acid-Induced Impurity Precipitation for Process Intensification in Monoclonal Antibody Purification. J. Biotechnol. 2018, 279, 13–21. [Google Scholar] [CrossRef]
- Gutiérrez, J.M.; Rojas, E.; Quesada, L.; León, G.; Núñez, J.; Laing, G.D.; Sasa, M.; Renjifo, J.M.; Nasidi, A.; Warrell, D.A.; et al. Pan-African Polyspecific Antivenom Produced by Caprylic Acid Purification of Horse IgG: An Alternative to the Antivenom Crisis in Africa. Trans. R. Soc. Trop. Med. Hyg. 2005, 99, 468–475. [Google Scholar] [CrossRef]
- Al-Abdulla, I.; Casewell, N.R.; Landon, J. Single-Reagent One-Step Procedures for the Purification of Ovine IgG, F(Ab′)2 and Fab Antivenoms by Caprylic Acid. J. Immunol. Methods 2014, 402, 15–22. [Google Scholar] [CrossRef]
- El-Ekiaby, M.; Vargas, M.; Sayed, M.; Gorgy, G.; Goubran, H.; Radosevic, M.; Burnouf, T. Minipool Caprylic Acid Fractionation of Plasma Using Disposable Equipment: A Practical Method to Enhance Immunoglobulin Supply in Developing Countries. PLoS Neglected Trop. Dis. 2015, 9, e0003501. [Google Scholar] [CrossRef]
- European Commission; Scientific Committee on Animal Health and Animal Welfare. The Welfare of Non-Human Primates Used in Research; Health and Consumer Protection Directorate-General, European Commission: Brussels, Belgium, 2002. [Google Scholar]
- Carvalho, C.; Gaspar, A.; Knight, A.; Vicente, L. Ethical and Scientific Pitfalls Concerning Laboratory Research with Non-Human Primates, and Possible Solutions. Animals 2019, 9, 12. [Google Scholar] [CrossRef]
- Buckley, L.A.; Chapman, K.; Burns-Naas, L.A.; Todd, M.D.; Martin, P.L.; Lansita, J.A. Considerations Regarding Nonhuman Primate Use in Safety Assessment of Biopharmaceuticals. Int. J. Toxicol. 2011, 30, 583–590. [Google Scholar] [CrossRef] [PubMed]
- Bjornson-Hooper, Z.B.; Fragiadakis, G.K.; Spitzer, M.H.; Chen, H.; Madhireddy, D.; Hu, K.; Lundsten, K.; McIlwain, D.R.; Nolan, G.P. A Comprehensive Atlas of Immunological Differences Between Humans, Mice, and Non-Human Primates. Front. Immunol. 2022, 13, 867015. [Google Scholar] [CrossRef] [PubMed]
- Miranda-Cruz, A.R.; Sánchez-Artigas, R.; Otero-Alfaro, O.; Góngora-Amores, W.; Cobos-Valdes, D.; Goya-Batista, Y.; Balboa-González, J.; Pérez-Martin, O. Using the caprylic acid in obtaining the horse immunoglobulin anti tetanus toxin. VacciMonitor 2014, 23, 63–72. [Google Scholar]
- Yu, I.T. Factor Screening with Modified One-Factor-at-a-Time Experiments. Commun. Stat. Simul. Comput. 2024, 53, 4449–4463. [Google Scholar] [CrossRef]
- Guidolin, F.R.; Caricati, C.P.; Marcelino, J.R.; da Silva, W.D. Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique. PLoS Neglected Trop. Dis. 2016, 10, e0004325. [Google Scholar] [CrossRef]
- Alomran, N.; Alsolaiss, J.; Albulescu, L.O.; Crittenden, E.; Harrison, R.A.; Ainsworth, S.; Casewell, N.R. Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms. PLoS Neglected Trop. Dis. 2022, 16, e0010511. [Google Scholar] [CrossRef]
- Blancher, C.; Jones, A. SDS -PAGE and Western Blotting Techniques. Methods Mol. Med. 2001, 57, 145–162. [Google Scholar] [CrossRef]
- Taherian, A.; Fazilati, M.; Moghadam, A.T.; Tebyanian, H. Optimization of Purification Procedure for Horse F(Ab´)2 Antivenom against Androctonus crassicauda (Scorpion) Venom. Trop. J. Pharm. Res. 2018, 17, 409–414. [Google Scholar] [CrossRef]
- Zheng, J.; Wang, L.; Twarowska, B.; Laino, S.; Sparks, C.; Smith, T.; Russell, R.; Wang, M. Caprylic Acid-Induced Impurity Precipitation from Protein A Capture Column Elution Pool to Enable a Two-Chromatography-Step Process for Monoclonal Antibody Purification. Biotechnol. Prog. 2015, 31, 1515–1525. [Google Scholar] [CrossRef]
- Morais, V.; Massaldi, H. A Model Mechanism for Protein Precipitation by Caprylic Acid: Application to Plasma Purification. Biotechnol. Appl. Biochem. 2012, 59, 50–54. [Google Scholar] [CrossRef]
- Redwan, E.R.M.; Fahmy, A.; EL Hanafy, A.; EL-Baky, N.A.; Sallam, S.M.A. Ovine Anti-Rabies Antibody Production and Evaluation. Comp. Immunol. Microbiol. Infect. Dis. 2009, 32, 9–19. [Google Scholar] [CrossRef]
- Latypov, R.F.; Hogan, S.; Lau, H.; Gadgil, H.; Liu, D. Elucidation of Acid-Induced Unfolding and Aggregation of Human Immunoglobulin IgG1 and IgG2 Fc. J. Biol. Chem. 2012, 287, 1381–1396. [Google Scholar] [CrossRef] [PubMed]
- Lopez, E.; Scott, N.E.; Wines, B.D.; Hogarth, P.M.; Wheatley, A.K.; Kent, S.J.; Chung, A.W. Low PH Exposure During Immunoglobulin G Purification Methods Results in Aggregates That Avidly Bind Fcγ Receptors: Implications for Measuring Fc Dependent Antibody Functions. Front. Immunol. 2019, 10, 2415. [Google Scholar] [CrossRef] [PubMed]
- Rojas, G.; Jiménez, J.; Gutiérrez, J. Caprylic acid fractionation of hyperimmune horse plasma: Description of a simple procedure for antivenom production. Toxicon 1994, 32, 351–363. [Google Scholar] [CrossRef] [PubMed]
- Eppler, A.; Weigandt, M.; Hanefeld, A.; Bunjes, H. Relevant Shaking Stress Conditions for Antibody Preformulation Development. Eur. J. Pharm. Biopharm. 2010, 74, 139–147. [Google Scholar] [CrossRef]
- Kiese, S.; Papppenberger, A.; Friess, W.; Mahler, H.C. Shaken, Not Stirred: Mechanical Stress Testing of an IgG1 Antibody. J. Pharm. Sci. 2008, 97, 4347–4366. [Google Scholar] [CrossRef]
- Raweerith, R.; Ratanabanangkoon, K. Fractionation of Equine Antivenom Using Caprylic Acid Precipitation in Combination with Cationic Ion-Exchange Chromatography. J. Immunol. Methods 2003, 282, 63–72. [Google Scholar] [CrossRef]
- Harris, R.J.; Shire, R.J.; Winter, C. Commercial Manufacturing Scale Formulation and Analytical Characterization of Therapeutic Recombinant Antibodies. Drug Dev. Res. 2004, 61, 137–154. [Google Scholar] [CrossRef]
- Sarciaux, J.M.; Mansour, S.; Hageman, M.J.; Nail, S.L. Effects of Buffer Composition and Processing Conditions on Aggregation of Bovine IgG during Freeze-Drying. J. Pharm. Sci. 1999, 88, 1354–1361. [Google Scholar] [CrossRef]





Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Ogopotse, W.; Musabyimana, V.; Khasandi, P.M.; Kotti, D.; Ngotho, M.; Kagira, J.M.; Oluoch, G.O. Optimisation of a Caprylic Acid-Based Protocol for IgG Purification from Baboon (Papio anubis) Serum. Methods Protoc. 2026, 9, 29. https://doi.org/10.3390/mps9010029
Ogopotse W, Musabyimana V, Khasandi PM, Kotti D, Ngotho M, Kagira JM, Oluoch GO. Optimisation of a Caprylic Acid-Based Protocol for IgG Purification from Baboon (Papio anubis) Serum. Methods and Protocols. 2026; 9(1):29. https://doi.org/10.3390/mps9010029
Chicago/Turabian StyleOgopotse, Wathuto, Valentine Musabyimana, Pamela M. Khasandi, Dennis Kotti, Maina Ngotho, John M. Kagira, and George O. Oluoch. 2026. "Optimisation of a Caprylic Acid-Based Protocol for IgG Purification from Baboon (Papio anubis) Serum" Methods and Protocols 9, no. 1: 29. https://doi.org/10.3390/mps9010029
APA StyleOgopotse, W., Musabyimana, V., Khasandi, P. M., Kotti, D., Ngotho, M., Kagira, J. M., & Oluoch, G. O. (2026). Optimisation of a Caprylic Acid-Based Protocol for IgG Purification from Baboon (Papio anubis) Serum. Methods and Protocols, 9(1), 29. https://doi.org/10.3390/mps9010029

